As head of science for Chan Zuckerberg Initiative and CZ Biohub Network, I'm often asked about our mission to help scientists cure, prevent or manage all diseases by the end of the century.
It’s ambitious. But is it really achievable? If so, how?
I want to bring you along as we reconsider our assumptions about what’s possible in science by sharing regular updates about how we’re accelerating biomedical research.
I’m particularly excited about the progress we’re making in AI to model cells and understand disease. At Stanford’s recent Big Ideas in Medicine conference, Michael Fischbach — the Liu (Liao) Family professor of bioengineering at Stanford University, an institute scholar of Stanford ChEM-H, and the director of the Stanford Microbiome Therapies Initiative — moderated a discussion with Priscilla Chan and me in which we discussed how using AI for basic research could help scientists explore novel therapies.
